In this Viewpoint, the former president of the Institute of Medicine discusses the importance of conflicts of interest to the integrity of the medical profession, and the importance of policies to manage conflicts of interest that are specific, clear, public, comprehensible, and fair.
This Viewpoint considers if conflict of interest (COI) is proportional to the size of financial payment or reward and how size and type of payment should be accounted for in attempts to manage COIs.
This Viewpoint argues that “potential” conflicts of interest (COIs) are actual COIs that are effectively managed, and calls for clear terminology to describe the severity of COIs and how they are identified and managed.
This Viewpoint explores the differences between financial and nonfinancial conflicts of interest, the effects of both on research bias, and the importance of managing each in ways that reduce bias.
This Viewpoint discusses the complexities of meaningful conflicts of interest, how they affect the integrity of the medical profession, and progress the profession has made in developing organizational responses to conflicts of interest.
This Viewpoint argues that a successful approach to managing financial conflicts of interest would involve strategies to identify and manage bias more generally.
This Viewpoint discusses the important role that leaders of academic medical centers (AMCs) play in fostering collaborations with industry while managing individual and institutional conflicts of interest (COI).
In this Viewpoint the dean of Harvard Medical School surveys the multifaceted aspects of conflict of interest among medical school faculty and urges a conflict-of-intererst research program to ensure objective and effective management of inevitable conflicts
This Viewpoint argues for the importance of medical school curricula and policies that educate students about conflicts of interest, their consequences, and how to manage them.
This Viewpoint considers when extramural funding might represent a conflict of interest for schools of public health and suggests approaches for managing institutional conflicts of interest.
This Viewpoint reviews relationships that professional medical associations (PMAs) can develop with commercial entities, the effects of conflicts of interest on PMA activities, including development of practice guidelines, and ways PMAs can prevent and manage adverse influences of those conflicts.
This Viewpoint proposes policies for managing conflicts of interest related to practice guideline development, including conflicts among guideline committee panelists and those that derive from guideline sponsors.
This Viewpoint discusses conflicts of interest associated with continuing medical education and proposes strategies to address their influence on continuing medical education activities.
This Viewpoint discusses the need for physicians and hospitals to disclose relevant financial interests to patients and challenges to effective disclosure of those interests, and suggests principles that might guide effective policies for approaches to disclosure.
This Viewpoint considers how payment models for clinical services create conflicts of interest in medical practice and how a salary model of payment might diminish the conflict and have other benefits.
This Viewpoint discusses the challenges to fully informing patients about physician conflicts of interest (COIs) and questions if attempts to improve COI transparency will make a difference to and for patients.
This Viewpoint describes the US government’s Open Payments program and initiatives by ProPublica, a nonprofit investigative news program, all of which make information about physicians’ financial relationships with drug companies and associated prescribing habits free and accessible to the public.
This Viewpoint discusses the conflicts of interest that arise from industry’s dual obligations to patients and shareholders and outlines progress academic medical centers and others have made managing conflicts of interest in industry-sponsored clinical research.
This Viewpoint discusses whether payments to physicians for food and beverages from the pharmaceutical industry and other health care companies influence physicians’ drug prescribing behaviors.
This Viewpoint discusses the role of the food industry in funding nutrition research, the risk of bias in nutritional evidence arising from funders’ conflicts of interest (COIs), and actions recommended by the CDC to manage those COIs.
This Viewpoint discusses the importance of high standards for editorial conflict of interest and suggests recusal procedures for editors that can help maintain the trust of readers.
This Viewpoint discusses the role of publishers and editors in managing conflict of interest policies and practices for medical journals.
This Viewpoint discusses the duty of authors to report potential conflicts of interest, the legal and professional consequences of omissions, and processes for investigating allegations of failure to disclose conflicts of interest.
This study uses Open Payments reporting data to describe industry payments to physicians in 2015 and to compare payments by physician specialty and sex.
This study compares changes in physician prescribing patterns before and after implementation of policies at academic medical centers restricting on-site activities of pharmaceutical salespeople.
This JAMA Professionalism article uses the hypothetical example of a specialist who performs procedures on all of his patients to discuss appropriate responses to conflict of interest in clincal practice.
This study describes characteristics of phase 1 trials, frequency of harms, and communication between investigators and research ethics committees about adverse events to characterize the safety and improve the regulatory review of UK phase 1 trials.
This Medical News article features an interview with 2 experts in field discussing the role of the microbiome in respiratory diseases.